Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer

NCT00075751 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

NIH

Sponsor class

Conditions

Recurrent Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: carboplatin
DRUG: bortezomib

Sponsor

National Cancer Institute (NCI)